SEI INVESTMENTS CO

Position in OCUL — Ocular Therapeutix, Inc

CIK 350894 OAKS, PA

Position in OCUL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,048,942

-$137,706 QoQ

Shares Held

208,650

-19.2% QoQ

Ownership

0.095%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#80

of 257 holders

Holding Since

Sep 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $1,244,722,378 across 210 Biotechnology names. OCUL ranks #53 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	255,073	$236,649,076
2	INSM	INSMED Inc	1,015,870	$108,312,059
3	VRTX	Vertex Pharmaceuticals Inc / Ma	129,981	$64,565,461
4	EXEL	Exelixis, Inc.	1,166,715	$63,480,962
5	ASND	Ascendis Pharma A/S	237,869	$63,444,419
6	INCY	Incyte Corp	498,013	$56,454,752
7	HALO	Halozyme Therapeutics, Inc.	551,116	$43,135,848
8	REGN	Regeneron Pharmaceuticals, Inc.	60,441	$37,687,380

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,048,942	208,650	-19.2%	Shares	Sole	2026-08-14
2026-03-31	$2,186,648	258,164	+52.2%	Shares	Sole	2026-05-13
2025-12-31	$2,059,830	169,673	+46.1%	Shares	Sole	2026-02-13
2025-09-30	$1,357,372	116,114	-24.4%	Shares	Sole	2025-11-13
2025-06-30	$1,426,057	153,670	+6.5%	Shares	Sole	2025-08-14
2025-03-31	$1,058,078	144,349	+420.3%	Shares	Sole	2025-05-14
2024-12-31	$236,916	27,742	+19.3%	Shares	Sole	2025-02-11
2024-09-30	$202,240	23,246	-69.1%	Shares	Sole	2024-11-12
2021-03-31	$1,234,851	75,250	+34.1%	Shares	Defined	2021-05-12
2020-12-31	$1,161,683	56,120	+443.3%	Shares	Defined	2021-02-08
2020-09-30	$78,611	10,330	—	Shares	Defined	2020-12-04
No filing history on record for this holder in this stock.